Intravenous delivery of AAV9-GLB1 gene therapy for GM1 gangliosidosis: An interim analysis

被引：0
|
作者：
D'Souza, Precilla [1 ]
Johnston, Jean M. [1 ]
Thurm, Audrey [2 ]
Farmer, Cristan [2 ]
Gross, Amanda L. [3 ]
Acosta, Maria T. [1 ]
Tifft, Cynthia [1 ]
机构：
[1] NHGRI, NIH, Bethesda, MD USA
[2] NIMH, NIH, Bethesda, MD USA
[3] Auburn Univ, Auburn, AL USA
来源：
MOLECULAR GENETICS AND METABOLISM | 2024年 / 141卷 / 02期
关键词：
D O I：
10.1016/j.ymgme.2023.107802
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
63
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Gene therapy approaches for GM1 gangliosidosis: Focus on animal and cellular studies
    Hosseini, Kamran
    Fallahi, Jafar
    Tabei, Seyed M. B.
    Razban, Vahid
    CELL BIOCHEMISTRY AND FUNCTION, 2023, 41 (08) : 1093 - 1105
  • [42] Comparing Efficacy of AAV Capsid Serotypes for the Treatment of Feline GM1 Gangliosidosis
    Garrett, Courtney
    Gross, Amanda L.
    Gray-Edwards, Heather L.
    Sena-Esteves, Miguel
    Martin, Douglas R.
    MOLECULAR THERAPY, 2024, 32 (04) : 525 - 525
  • [43] Effect of Administration Route and AAV Serotype for Treatment of Feline GM1 Gangliosidosis
    Gross, Amanda L.
    Gray-Edwards, Heather
    Sena-Esteves, Miguel
    Martin, Douglas R.
    MOLECULAR THERAPY, 2020, 28 (04) : 217 - 218
  • [44] A computational approach to analyse the amino acid variants of GLB1 protein causing GM1 Gangliosidosis
    K. Priyanka
    N. Madhana Priya
    R. Magesh
    Metabolic Brain Disease, 2021, 36 : 499 - 508
  • [45] Phase 1/2 Trial of AXO-AAV-GM1 Gene Therapy for the Treatment of Infantile- and Juvenile-onset GM1 Gangliosidosis: Preliminary Results
    Tifft, C.
    D'souza, P.
    Johnston, J.
    Acosta, M.
    Rothermel, C.
    Thurm, A.
    Karunakara, A.
    Thorp, B.
    Ross, P.
    Jameson, J.
    Vaughn, T.
    Valencia, D.
    De Boever, E.
    Corcoran, G.
    ANNALS OF NEUROLOGY, 2021, 90 : S98 - S98
  • [46] A computational approach to analyse the amino acid variants of GLB1 protein causing GM1 Gangliosidosis
    Priyanka, K.
    Priya, N. Madhana
    Magesh, R.
    METABOLIC BRAIN DISEASE, 2021, 36 (03) : 499 - 508
  • [47] Intracerebral cell transplantation therapy for murine GM1 gangliosidosis
    Sawada, Tomo
    Tanakaa, Akemi
    Higaki, Katsumi
    Takamura, Ayumi
    Nanba, Eiji
    Seto, Toshiyuki
    Maeda, Mitsuyo
    Yamaguchi, Etsuko
    Matsuda, Junichiro
    Yamano, Tunekazu
    BRAIN & DEVELOPMENT, 2009, 31 (10): : 717 - 724
  • [48] Application of a pentasaccharide biomarker to access treatment efficacy of gene therapy for GM1 gangliosidosis
    Kell, Pamela
    Mishra, Sonali
    D'Souza, Precilla
    Tifft, Cynthia J.
    Jiang, Xuntian
    MOLECULAR GENETICS AND METABOLISM, 2024, 141 (02)
  • [49] Development and validation of enzyme replacement therapy for GM1 gangliosidosis
    Brown, Jillian R.
    Glass, Kimberly
    Glass, Charles A.
    Davis, Crystal
    Lutz, Cathleen
    Waggoner, Christine
    MOLECULAR GENETICS AND METABOLISM, 2023, 138 (02) : 20 - 20
  • [50] Systemic AAV9 gene transfer in adult GM1 gangliosidosis mice reduces lysosomal storage in CNS and extends lifespan
    Weismann, Cara M.
    Ferreira, Jennifer
    Keeler, Allison M.
    Su, Qin
    Qui, Linghua
    Shaffer, Scott A.
    Xu, Zuoshang
    Gao, Guangping
    Sena-Esteves, Miguel
    HUMAN MOLECULAR GENETICS, 2015, 24 (15) : 4353 - 4364
12345